HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bacitracin therapy in antibiotic-associated pseudomembranous colitis.

Abstract
Two patients with antibiotic-associated pseudomembranous colitis, and stool positive for Clostridium difficile cytotoxin were successfully treated with oral bacitracin. One patient had previously suffered two relapses of pseudomembranous colitis following successful treatment with vancomycin and one patient was allergic to vancomycin. Bacitracin appears to be a reasonable choice to treat patients with antibiotic-associated colitis who are allergic to vancomycin. Further studies comparing vancomycin and bacitracin are needed.
AuthorsF J Tedesco
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 25 Issue 10 Pg. 783-4 (Oct 1980) ISSN: 0163-2116 [Print] United States
PMID6903494 (Publication Type: Case Reports, Comparative Study, Journal Article)
Chemical References
  • Cephalosporins
  • Bacitracin
  • Vancomycin
  • Ampicillin
Topics
  • Adult
  • Ampicillin (therapeutic use)
  • Bacitracin (therapeutic use)
  • Cephalosporins (therapeutic use)
  • Clostridium (drug effects)
  • Clostridium Infections (drug therapy)
  • Enterocolitis, Pseudomembranous (drug therapy, etiology)
  • Female
  • Humans
  • Male
  • Penicillin Resistance
  • Urinary Tract Infections (drug therapy, microbiology)
  • Vancomycin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: